Sign in →

Test Code FENTRU Fentanyl Drug Screen Urine

Additional Codes

Cerner

NextGen

Tox U Fentanyl Drug Screen

Tox U Fentanyl Drug Screen

Fentanyl Drug Screen

 

Alternate Name(s)

Sublimaze

Innovar

Methodology

Enzyme Immunoassay

Patient Preparation

None

Collection Instructions

Catheterized specimens collected according to clinical policies and procedures

Radom clean catch instructions: Random Urine Collection Instructions

Specimen Requirements

Container

  • Sterile/clean plastic urine container

 or  or 

  • Non-preservative urine tube (BD Vacutainer® Ref #364980)

Stability

Storage

Temperature

Stability

Room Temperature

18-28°C

≤ 2 hours

 

Refrigerated

 2-8°C

≤ 7 days

 

Frozen

≤-20 °C

Acceptable for 6 months. Thaw and mix thoroughly before testing.

Rejection Criteria

Not Defined

Result Reporting and Reference Values

  • Results are reported as Negative or Positive (cutoff >1.0 ng/mL)
  • This is a screening result only.

Reflex Testing

None

Limitations

  • Unconfirmed screening result - Suggest confirmation if clinically indicated. For medical purposes only. Unconfirmed screening results are not to be used for non-medical purposes, i.e. employment testing or legal testing.
  • This test has been modified and its performance characteristics determined by Fairbanks Memorial Hospital Laboratory. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.

Useful For

Fentanyl [N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylpropanamide] is a synthetic opioid narcotic analgesic similar to morphine. Fentanyl is 50-100 times more potent than morphine. It is prescribed for patients with chronic pain and is used to manage pain after surgery or for treatment of breakthrough pain in cancer patients. Fentanyl is prescribed in various forms: by injection (intravenous or intramuscular), transdermal patch, and orally (transmucosal lozenge or film). Fentanyl can be abused in a manner similar to other opioid agonists, legal or illicit. All patients receiving opioids should be routinely monitored for signs of misuse, abuse and addiction. Fentanyl has high potency and short duration of action, and is abused for its intense euphoric effects. It is very dangerous when illicitly substituted for other opioids due to its potency, and overdoses can lead to respiratory depression and death. It is a Schedule II substance under the U.S. Controlled Substances Act.

The ARK Fentanyl II Assay is an immunoassay intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL. In order to obtain a confirmed positive analytical result, a more specific alternative method must be used. Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/tandem Mass Spectrometry (LC-MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be exercised with any drug test result, particularly when the preliminary test result is positive.